Blue Water Life Science Advisors, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 8 US equity positions worth $113.7m in its Q3 2024 13F filing. The largest position was NTRA at 32.5% of the reported book, followed by CDNA and EXK.
What did Blue Water Life Science Advisors, LP own in Q3 2024? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 32.5% | $37.0m | 291,094 | – | |
| 2 | CDNA CAREDX INC | Healthcare | 16.6% | $18.9m | 604,000 | – | |
| 3 | EXK EXACT SCIENCES CORP | Basic Materials | 15.3% | $17.4m | 255,243 | – | |
| 4 | AKOYA BIOSCIENCES INC | 11.2% | $12.8m | 4,697,785 | – | ||
| 5 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 9.7% | $11.0m | 2,145,145 | – | |
| 6 | GH GUARDANT HEALTH INC | Healthcare | 9.1% | $10.3m | 451,047 | – | |
| 7 | PSNL PERSONALIS INC | Healthcare | 4.7% | $5.4m | 1,000,000 | – | |
| 8 | QTRX QUANTERIX CORP | Healthcare | 0.9% | $1.0m | 78,393 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.